The fees payable shall be reduced in the case of a clinical evaluation consultation procedure initiated in accordance with point (c) of Section 5.1 of Annex IX involving a manufacturer who is a micro, small or medium-sized enterprise within the meaning of Recommendation 2003/361/EC.
Déanfar na táillí is iníoctha a laghdú iad i gcás nós imeachta do chomhairliúchán meastóireachta cliniciúla, ar nós imeachta é a thionscnaítear i gcomhréir le pointe (c) de Roinn 5.1 d'Iarscríbhinn IX a bhfuil baint aige le monaróir ar micrifhiontar, fiontar beag nó fiontar meánmhéide é de réir bhrí Mholadh 2003/361/CE.